Pancreatic Cancer Research

ResearcherUniversity of PaduaActive in the last 2 years

Paolo Simioni

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6744-383X; OpenAlex author ID A5031677659. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
12
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper

Papers 4

  1. Cellular Components Contributing to the Development of Venous Thrombosis in Patients with Pancreatic Cancer. Co-author DOI 10.1055/s-0043-1777304↗
  2. Contact system and intrinsic pathway activation in patients with advanced pancreatic cancer: a prospective cohort study. Last author DOI 10.1016/j.jtha.2023.06.009↗
  3. Mechanisms of thrombosis in pancreatic ductal adenocarcinoma. Last author DOI 10.1016/j.beha.2022.101346↗
  4. The relationship between pancreatic cancer and hypercoagulability: a comprehensive review on epidemiological and biological issues. Co-author DOI 10.1038/s41416-019-0510-x↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Elena Campello · 4 shared papers, 2019–2024 · strength 0.72
  2. Floris T.M. Bosch · 2 shared papers, 2022–2023 · strength 0.36
  3. Nigel S. Key · 2 shared papers, 2019–2023 · strength 0.29
  4. Ruth A.L. Willems · 1 shared paper, 2024 · strength 0.23
  5. Hugo ten Cate an · 1 shared paper, 2024 · strength 0.23
  6. Mark Roest · 1 shared paper, 2024 · strength 0.23
  7. Judith de Vos‐Geelen · 1 shared paper, 2024 · strength 0.23
  8. Nick van Es · 1 shared paper, 2023 · strength 0.15
  9. Hanneke W. Wilmink · 1 shared paper, 2023 · strength 0.15
  10. Antonio Pea · 1 shared paper, 2023 · strength 0.15
  11. Harry Roger Buller · 1 shared paper, 2023 · strength 0.15
  12. Roberto Salvia · 1 shared paper, 2023 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.